In vitro susceptibilities of mycoplasmas and ureaplasmas to new macrolides and aryl-fluoroquinolones.

In vitro activities of the new macrolides clarithromycin, previously designated A-56268 (TE-031), and A-63075 and of the aryl-fluoroquinolones difloxacin (A-56619) and temafloxacin (A-62254) against 14 strains of Mycoplasma pneumoniae, 20 strains of Mycoplasma hominis, and 28 strains of Ureaplasma u...

Descrizione completa

Dettagli Bibliografici

Pubblicato in:	Antimicrob Agents Chemother
Autori principali:	Waites, K B, Cassell, G H, Canupp, K C, Fernandes, P B
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	American Society for Microbiology (ASM) 1988
Soggetti:	Research Article
Accesso online:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC175906/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2973283/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.32.10.1500
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!